Search

Author/Creator Monnet, I

1. 1142PDEfficacy of immune checkpoint inhibitors in lung sarcomatoid carcinoma: Data from a French multicentric cohort. (23rd October 2018)

Authors:
Domblides, C; Monnet, I; Mazieres, J; Barlesi, F; Gounant, V; Baldacci, S; Mennecier, B; Toffart, A C; Audigier Valette, C; Doucet, L; Giroux-Leprieur, E; Guisier, F; Molinier, O; Perol, M; Pichon, E; Robinet, G; Templement Grangerat, D; Ruppert, A-M; Wislez, M
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. LBA4Long-term follow-up in the KEYNOTE-010 study of pembrolizumab (pembro) for advanced NSCLC, including in patients (pts) who completed 2 years of pembro and pts who received a second course of pembro. (17th December 2018)

Authors:
Herbst, R S; Garon, E B; Kim, D-W; Chul Cho, B; Pérez Gracia, J L; Han, J-Y; Dubos Arvis, C; Majem, M; Forster, M; Monnet, I; Novello, S; Szalai, Z; Gubens, M A; Su, W-C; Ceresoli, G L; Samkari, A; Jensen, E; Lubiniecki, G M; Baas, P
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 10
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 154PPD-L1 expression pattern in large cell neuroendocrine carcinoma of the lung. (23rd October 2018)

Authors:
Damotte, D; Charpentier, M C; Bernardi, M; Watkin, E; Goubin Versini, I; Lamy, R; Piton, N; Geriniere, L; Forest, F; Gervais, R; Monnet, I; Madrosyk, A; Guisier, F; Serrand, C; Locher Genty, C; Decroisette, C; Auliac, J B; Jeanfaivre, T; Doubre, H; Arpin, D
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. LBA63Long-term survival in patients (pts) with advanced NSCLC in the KEYNOTE-010 study overall and in pts who completed two years of pembrolizumab (pembro). (23rd October 2018)

Authors:
Herbst, R S; Garon, E B; Kim, D-W; Chul Cho, B; Pérez Gracia, J L; Han, J-Y; Dubos Arvis, C; Majem, M; Forster, M; Monnet, I; Novello, S; Szalai, Z; Gubens, M A; Su, W-C; Ceresoli, G L; Samkari, A; Jensen, E; Lubiniecki, G M; Baas, P
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. 81P Efficacy of weekly paclitaxel-bevacizumab combination in advanced non squamous non-small cell lung cancer (NSCLC) progressing after immune checkpoint inhibitors - AVATAX, a retrospective multicentric study: Preliminary data. (15th December 2019)

Authors:
Valery, S C; Chouaid, C; Rousseau-Bussac, G; Monnet, I; Bilger, G; Boré, P; Pinsolle, J; Descourt, R; Geier, M; Toffart, A C; Cony-Makhoul, P; Robinet, G; Ennahdi, F; Zaccaria, I; Decroisette, C
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 11
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial. (4th October 2019)

Authors:
Moro-Sibilot, D; Cozic, N; Pérol, M; Mazières, J; Otto, J; Souquet, P J; Bahleda, R; Wislez, M; Zalcman, G; Guibert, S D; Barlési, F; Mennecier, B; Monnet, I; Sabatier, R; Bota, S; Dubos, C; Verriele, V; Haddad, V; Ferretti, G; Cortot, A
Journal:
Annals of oncology
Issue:
Volume 30:Number 12(2019)
Page Start:
1985
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗